Brian S. Tyler, chief executive officer of McKesson Corporation (MCK), has been a consistent seller of company stock over the past year, with no open-market purchases recorded in his recent Form 4 filings. Across 56 total transactions spanning two companies, his sales total approximately $93.7 million, while his only acquisitions have been small equity grants and option exercises valued at roughly $12,900. The selling pattern is pronounced: seven open-market sales occurred in the last reporting period alone, including a $13.7 million disposition on June 6, 2025, and an $8.4 million sale on August 22, 2025. More recently, he sold $6.7 million worth of MCK shares on July 7, 2026, and $6.6 million on June 17, 2026, continuing a steady cadence of large-dollar exits.
The bulk of Tyler’s activity centers on MCK, where he also received routine equity awards and exercised options valued at zero on the filing dates, followed by automatic share withholdings to cover tax obligations—transactions that are mechanical rather than discretionary. His secondary holding, Republic Services (RSG), shows a contrasting pattern: only small quarterly grants of roughly $2,300 to $3,300, a gift, and an option exercise, with no sales at all. This asymmetry suggests Tyler is monetizing his McKesson position while maintaining a passive stake in the waste-management firm.
Notably, Tyler has not executed a single open-market purchase of either stock during the observed window, and his recent activity is dominated by sales—seven in the latest period versus zero buys. The dollar values are substantial, with individual MCK sales ranging from $3.8 million to $13.7 million, indicating a deliberate reduction of his equity exposure in the healthcare distributor. While the filings do not reveal his reasoning, the data clearly show a seller’s bias in McKesson shares, tempered by routine compensation-related transactions that are standard for an executive in his role.
AI-assisted summary